Stock Events

Avid Bioservices 

$7.21
21
-$0.33-4.38% Monday 20:00

Statistics

Day High
7.84
Day Low
7.15
52W High
14.33
52W Low
4.07
Volume
686,187
Avg. Volume
1,032,229
Mkt Cap
457.69M
P/E Ratio
1,758.54
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26JunConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Next
-0.12
-0.06
0.01
0.07
Expected EPS
-0.035
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDMO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

10$Average Price Target
The highest estimate is $12.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Medical Specialties
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Show more...
CEO
Nicholas Green
Employees
365
Country
US
ISIN
US05368M1062
WKN
000A2JBKV

Listings